Stability Study of mRNA-Lipid Nanoparticles Exposed to Various Conditions Based on the Evaluation between Physicochemical Properties and Their Relation with Protein Expression Ability

Lipid nanoparticles (LNPs) are currently in the spotlight as delivery systems for mRNA therapeutics and have been used in the Pfizer/BioNTech and Moderna COVID-19 vaccines. mRNA-LNP formulations have been indicated to require strict control, including maintenance at fairly low temperatures during th...

Повний опис

Бібліографічні деталі

Автори:	Mariko Kamiya, Makoto Matsumoto, Kazuma Yamashita, Tatsunori Izumi, Maho Kawaguchi, Shusaku Mizukami, Masako Tsurumaru, Hidefumi Mukai, Shigeru Kawakami
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2022-10-01
Серія:	Pharmaceutics
Предмети:	mRNA-LNP storage condition stability
Онлайн доступ:	https://www.mdpi.com/1999-4923/14/11/2357
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!